Camurus Revenue and Competitors
Estimated Revenue & Valuation
- Camurus's estimated annual revenue is currently $61.7M per year.
- Camurus's estimated revenue per employee is $201,000
Employee Data
- Camurus has 307 Employees.
- Camurus grew their employee count by 5% last year.
Camurus's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | Chief Business Development Officer | Reveal Email/Phone |
3 | VP, Head Market Access | Reveal Email/Phone |
4 | Head Marketing and Communications (UKI) | Reveal Email/Phone |
5 | Head Compliance | Reveal Email/Phone |
6 | VP Regulatory Affairs | Reveal Email/Phone |
7 | Head Medical Affairs | Reveal Email/Phone |
8 | Head Medical Affairs Central Europe | Reveal Email/Phone |
9 | Head Marketing & Business Operations CEU | Reveal Email/Phone |
10 | Head Market Access & Public Policy | Reveal Email/Phone |
Camurus Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $21.3M | 106 | 25% | N/A | N/A |
#2 | $61.7M | 307 | 5% | N/A | N/A |
#3 | $15.1M | 75 | -12% | N/A | N/A |
#4 | $120.6M | 600 | 22% | N/A | N/A |
#5 | $29.7M | 148 | 21% | N/A | N/A |
#6 | $27.7M | 138 | -67% | N/A | N/A |
#7 | $31.2M | 155 | 14% | N/A | N/A |
#8 | $25.3M | 126 | 29% | N/A | N/A |
#9 | $108.7M | 541 | 26% | N/A | N/A |
#10 | $1200M | 1397 | -6% | $2.4B | N/A |
What Is Camurus?
Camurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus clinical pipeline includes products for treatment of cancer, endocrine diseases, pain and addiction, developed in-house and in collaboration with international pharmaceutical companies. The company's shares are listed on Nasdaq Stockholm under the ticker CAMX.
keywords:N/AN/A
Total Funding
307
Number of Employees
$61.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Camurus News
Nanotechnology in Drug Delivery Market Size, Share, Growth 2022-2029| Key Players Access Pharmaceuticals, Alkermes, Aquanova, Camurus.
... for the Forecast Period Between 2022 to 2028: BioDelivery Sciences, Camurus, Carlina Technologies, Cerulean Pharma, Nano Green Sciences.
Camurus : Proposal by the Board on authorization for the Board of Directors to resolve on issues · 1. The authorization may be exercised on one...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $61.6M | 340 | -15% | N/A |
#2 | $70M | 386 | 18% | N/A |
#3 | $79.3M | 453 | 6% | N/A |
#4 | $209.1M | 478 | -3% | N/A |
#5 | $142.5M | 543 | 10% | N/A |